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In Brief
Because of low throughput and
limited robustness, nano-scale
liquid chromatography has been
a bottleneck for advancing pro-
teomics in biomedical research.
Here, we developed and evalu-
ated two new LC concepts—
“pre-formed gradients” and
“offset gradients for peptide re-
focusing”—that are both imple-
mented in the Evosep One in-
strument. We evaluated
robustness with more than 2000
HeLa runs, demonstrated ab-
sence of cross-contamination
with crude plasma samples, high
proteome coverage by fraction-
ated HeLa and routinely meas-
uring more than 5000 proteins/
sample in just 21 minutes.
Graphical Abstract
Highlights
• Pre-formed and offset gradients for high throughput, robustness and peptide re-focusing.
• Minimal cross-contamination by disposable trap columns and partial elution.
• Single shot DIA measurements achieve 5000 proteins in 21 min.
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A Novel LC System Embeds Analytes in
Pre-formed Gradients for Rapid,
Ultra-robust Proteomics*□S
Nicolai Bache‡, Philipp E. Geyer§¶, Dorte B. Bekker-Jensen¶, Ole Hoerning‡,
Lasse Falkenby‡, Peter V. Treit§, Sophia Doll§, Igor Paron§, Johannes B. Mu¨ller§,
Florian Meier§, Jesper V. Olsen¶, Ole Vorm‡, and Matthias Mann§¶**
To further integrate mass spectrometry (MS)-based pro-
teomics into biomedical research and especially into clin-
ical settings, high throughput and robustness are essen-
tial requirements. They are largely met in high-flow rate
chromatographic systems for small molecules but these
are not sufficiently sensitive for proteomics applications.
Here we describe a new concept that delivers on these
requirements while maintaining the sensitivity of current
nano-flow LC systems. Low-pressure pumps elute the
sample from a disposable trap column, simultaneously
forming a chromatographic gradient that is stored in a
long storage loop. An auxiliary gradient creates an offset,
ensuring the re-focusing of the peptides before the sep-
aration on the analytical column by a single high-pressure
pump. This simplified design enables robust operation
over thousands of sample injections. Furthermore, the
steps between injections are performed in parallel, reduc-
ing overhead time to a few minutes and allowing analysis
of more than 200 samples per day. From fractionated
HeLa cell lysates, deep proteomes covering more than
130,000 sequence unique peptides and close to 10,000
proteins were rapidly acquired. Using this data as a li-
brary, we demonstrate quantitation of 5200 proteins in
only 21 min. Thus, the new system - termed Evosep One -
analyzes samples in an extremely robust and high
throughput manner, without sacrificing in depth proteom-
ics coverage. Molecular & Cellular Proteomics 17:
10.1074/mcp.TIR118.000853, 2284–2296, 2018.
Bottom-up proteomics is a highly successful and generic
technology, which now allows the analysis of complex sam-
ples ranging from bacteria through cell line systems and even
human tissue samples (1). State-of-the-art workflows begin
with a robust sample preparation to digest proteins and har-
vest purified peptides (2), which are separated by a liquid
chromatography (LC)1 system before they are analyzed by a
mass spectrometer (MS). Established software solutions au-
tomatically interpret the acquired spectra, generating lists of
thousands of quantified proteins (3–8).
The current performance level is a result of improvements
not only in the mass spectrometric components but also the
chromatographic part of the LC-MS workflow. In the quest for
ever increasing chromatographic separation power, columns
have become longer and particle sizes smaller - now reaching
the sub 2 m range. This may require pump pressures more
than 1000 bar, presenting great engineering challenges for
both the pumps and the entire LC system, often limiting
robustness in routine operation. Thus, chromatography re-
mains a weak link in MS-based proteomics workflows, lead-
ing to calls for new approaches (9). Furthermore, irreproduc-
ibility of retention times within and between laboratories
severely limits strategies that rely on the transfer of accurate
retention times, especially targeted proteomics (10), data in-
dependent acquisition (11) and “match between runs” at the
MS level (12, 13).
There is great interest in applying the increasing power of
MS-based proteomics to diagnostic and clinical questions
(14). “Clinical proteomics”, however, requires far more stabil-
ity and reproducibility than that available even in the most
advanced MS-based proteomics laboratories. Note that irre-
producibility and robustness issues are not features of LC-MS
per se, as the measurement of small molecules is firmly es-
tablished in clinical laboratories around the world, which rou-
tinely measure hundreds of samples per day. The two key
differences of these LC systems to the one applied in pro-
teomics are their much larger column diameters (20-fold) and
flow rates (1000-fold), making them much easier to control
and less error-prone. Increasing the flow rates to achieve
greater robustness has already been advocated in the context
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of cancer proteomics (15). However, the signal intensity in
electrospray ionization is concentration dependent and re-
ducing sensitivity at higher flow rates, which limits these
approaches to a few l/min. Apart from high robustness,
throughput is the other central requirement for MS-based
proteomics, if it is to enter routine clinical use. Instead, current
proteomics workflows generally employ fractionation—multi-
plying measurement time—or use relatively long gradient
times.
In a recent large-scale plasma proteomics study measured
in our laboratory, involving more than a thousand samples,
80% of the overall down time was attributable to the HPLC
system rather than the MS. At the same time, column equili-
bration, loading and washing steps between runs limited the
attractiveness of very short gradients (16, 17).
Several years ago, some of the current authors devised a
very different sample loading and injection approach. Termed
speLC, for solid-phase-extraction (nano) liquid chromatogra-
phy, it was intended for very high sample throughput needed
for clinical application (18). The speLC made use of the same
StageTips that are commonly employed in proteomics for
micro-scale purification of peptides and crude manual frac-
tionation (19–21). Instead of eluting into the autosampler vial
of the HPLC system, a low-pressure pump passed a 5–10 min
gradient through the StageTip itself and directly toward the
MS. The speLC system can analyze 192 E. coli samples in
only 30 h, as well as identifying more than 500 proteins from
a HeLa cell lysate in less than 10 min (18). In subsequent work,
speLC was combined with pre-fractionation such as 1D gel
electrophoresis or strong cation exchange (SCX), capitalizing
on its ability to analyze each of the fractions in 10 min or less
(22). Although useful for simple protein mixtures, the low-
pressure elution from StageTips and use of only very short
analytical columns inherently limited chromatographic sepa-
ration power of this system.
In the work reported here, we aimed to preserve the ben-
efits of the original speLC device while also achieving the
desirable features of modern HPLC instruments. We realized
this goal by coupling elution through the StageTips to a novel
downstream workflow. In the Evosep One design, peptides
are eluted at low pressure and flow rates of tens of l/min
from a special StageTip - termed EvotipTM. Notably, the gra-
dient along with the eluted analytes are captured in a long
capillary loop. A single high-pressure pump then applies the
stored gradient to an analytical nano-scale column. This re-
sults in undiminished chromatographic separation perform-
ance while eliminating the need to form a gradient at high
pressure. Thus, this layout marries the convenience and ro-
bustness of large columns, high-flow systems with the sensi-
tivity of narrow column diameters and low-flow rates of
nano-LC systems. We further detail the principle of operation
and development of the Evosep instrument in detail and inves-
tigate its robustness, throughput, and reproducibility in typical
applications encountered in MS-based proteomics.
EXPERIMENTAL PROCEDURES
Description of the Liquid Chromatography System—The Evosep
One incorporates four low-pressure single stroke piston pumps (A, B,
C, and D) and one high-pressure single stroke piston pump (HP) (Fig.
1A; supplemental Fig. S1A, S1B). Together they create a separate
low- and high-pressure sub-system. Each pump is equipped with a
pressure and flow sensor to monitor and precisely control the flow of
the individual solvent. A custom 12-port valve (operating at low-
pressure) diverts the flow of the low-pressure pumps either toward
the solvent bottles (sol A, sol B) for refilling or toward the system for
analysis. The high-pressure pump has a separate 6-port valve (oper-
ating at high-pressure) for refilling.
The only common flow path is a storage loop, which is either
connected to the low- or high-pressure sub-system and is controlled
by a 6-port rotary valve (Fig. 1A). In this way, the high-pressure
sub-system is always connected to the analytical or separation col-
umn but is either in-line or bypasses the storage loop. In contrast, the
low-pressure sub-system is always connected to waste but either
in-line or bypassing the storage loop. Thus, the storage loop becomes
the bridge between the low- and high-pressure sub-systems.
The separate steps are illustrated in the timetable and in the flow
path diagrams, highlighting the individual stages of an LC-MS run
(Fig. 1B, supplemental Fig. S2–S9). At the beginning of a new LC-MS
run, the XYZ-axis manipulator of the Evosep One picks up an indi-
vidual disposable trap column (Evotip) with its ceramic needle and
positions it in-line with the solvent flow path at the A/B/C/D mixing
cross (Fig. 1A, supplemental Fig. S1A, S1B).
In the second step, pumps A and B then form a primary gradient at
the A/B mixing tee that flows through the disposable trap column,
eluting the analytes of interest (Fig. 1B, supplemental Fig. S2). The
organic content of this initial gradient is limited to less than 35% to
ensure that only peptides of interest are eluted off the tips while
unwanted compounds such as polymers, lipids, and other highly
hydrophobic compounds remain bound to the single-use, disposable
tips along with any particulate matter from the loaded samples. Fur-
thermore, the final elution volume of this initial gradient is limited to
few l to ensure very precise elution and minimize bleeding of the
more hydrophobic molecules. This “partial elution” concept will be
further described in RESULTS AND DISCUSSION.
The two additional low-pressure pumps, C and D then modify the
eluent at the mixing cross A/B/C/D to create an “offset” to the initial
gradient (supplemental Fig. S2). This has the purpose of lowering the
organic contents, such that the analytes are initially retained on the
analytical column. The offset gradient with the embedded analytes is
moved into the storage loop before being switched in-line with the
high-pressure pump. In parallel to the first two steps, the high-
pressure pump is filled (supplemental Fig. S3) and the analytical
column is equilibrated (supplemental Fig. S4). Subsequently, the
Evosep One switches the storage loop in-line with the high-pressure
pump and the preformed gradient with the embedded analytes is
pushed toward the analytical column for high performance separation
(supplemental Fig. S5). In parallel to the LC-MS run, the Evosep One
is prepared for the next sample by ejecting the disposable trap
column, washing the mixing cross A/B/C/D and the ceramic needle,
refilling the low-pressure pumps and aligning the solvents of the
low-pressure pumps (Fig. 1B, supplemental Fig. S6–S9).
The instrument contains procedures to monitor its state during an
LC run and can detect high pressure in different parts of the system,
warns of potential leaks or the lack of an Evotips in the designated
autosampler position. It also has built in trouble shooting procedures1 The abbreviation used is: LC, liquid chromatography.
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through the Chronos software user interface. Moreover, the Evosep
One carries out preparatory actions before a sample run.
Cell Culture—HeLa cells were cultured in high glucose DMEM with
10% fetal bovine serum and 1% penicillin-streptomycin (Life Tech-
nologies, Inc.). Cells were counted using an Invitrogen countess cell
counter and stored after snap freezing at 80 °C.
Tryptophan Fluorescence Emission Assay for Protein Quantifica-
tion—Protein concentrations were determined in 8 M urea by trypto-
phan fluorescence emission at 350 nm, using an excitation wave-
length of 295 nm. Tryptophan at a concentration of 0.1 g/l in 8 M
urea was used to establish a standard calibration curve (0–4 l). We
estimated that 0.1 g/l tryptophan are equivalent to the emission of
7 g/l of human protein extract, if tryptophan on average accounts
for 1.3% of human protein amino acid composition.
Protein Digestion—For sample preparation we used the iST kit for
proteomic samples (2), starting with 106 HeLa cells according to the
manufacturer’s instructions (P.O. 00001, PreOmics GmbH).
Robustness Optimization—To test and optimize robustness, we
injected and analyzed over 2000 times tryptic peptides of HeLa cells,
initially in exploratory batches. For this experiment, we used the
breadboard model of the Evosep One coupled to a LTQ Orbitrap
instrument. All issues were protocolled, and the system was opti-
mized during the test and in the exploratory phase, the instrument
was only stopped for the optimization of hardware and software
components. The last 1500 HeLa samples were analyzed on a
single column to analyze variation in the system and the wear of the
column.
Plasma Proteomics—Blood was taken by venipuncture using a
commercially available winged infusion set and collection tubes con-
taining EDTA and centrifuged for 15 min at 2000  g to harvest
plasma. Blood was sampled from a healthy donor, who provided
written informed consent, with prior approval of the ethics committee
of the Max Planck Society. The plasma was distributed into a
96-well plate and subsequently processed with an automated sam-
FIG. 1. Evosep One flow diagram and time schedule. A, Almost all of the system runs at low pressure (10–20 bar), increasing the lifetime
and robustness of the LC. Only a single pump and flow path operates at high pressure and this does not involve any solvent mixing. B, Stepwise
timetable including all steps that the Evosep One is performing during a LC-MS run for the 60 samples/day method. The activities for the
autosampler, the low-pressure pumps and the high-pressure pump are color-coded in green, yellow and blue, respectively. For a detailed flow
diagram with highlighted flow path states see supplemental Fig. S2–S9.
Pre-formed Gradient Liquid Chromatography
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ple preparation for Plasma Proteome Profiling as described previ-
ously (16).
High Throughput of Low Complexity Samples—the “UPS1 Pro-
teomic Standard” (Sigma-Aldrich) was digested as indicated above
using the PreOmics iST kit and the peptides were analyzed with the
200 samples/day method (5.6 min gradient) with a 2 l/min flow on a
5 cm C18 column (3 m particle size).
Prefractionation—Peptides for deep proteome analysis were frac-
tionated using a reversed-phase Acquity CSH C18 1.7 m 1  150
mm column (Waters, Milford, MA) on an Ultimate 3000 high-pressure
liquid chromatography (HPLC) system (Dionex, Sunnyvale, CA) oper-
ating at 30 l/min. Buffer A (5 mM ammonium bicarbonate) and buffer
B (100% ACN) were used. Peptides were separated by a linear
gradient from 5% B to 35% B in 55 min, followed by a linear increase
to 70% B in 8 min. In total, 46 fractions were collected without
concatenation. For nano-flow LC-MS/MS, the loading amount was
kept constant at 500 ng per injection for the Easy-nLC 1200, while
500 ng from each fraction was loaded on an Evotip.
UV Gradient Storage Experiment—To assess the effect of diffusion
as a function of storage time in a storage loop, we built a test rig to
mimic Evosep One operation as illustrated in figure 2. A set of Zirco-
nium nano pumps (Prolab Instruments, GmbH, Switzerland, pump A:
0.1% formic acid (FA) in H2O, Pump B: 0.1% FA, 1% acetone in
acetonitrile) were programed to create the following composition
profile: 0–5 min 5% B, 5–10 min 5–95% B, 10–13 min 95% B, 13–15
min 95–5%, 15–18 min 5%, 18–23 min 5–95% B, 23–25 min 95% B,
25–27 min 95–5% B, 27–30 min 5% B. This was delivered into a
coiled (diameter 10 cm) fused silica storage loop (length 7 m, i.d. 100
m, OD375, Polymicro Technologies). After a specified storage time
had passed, a third Zirconium pump pushed the content out of the
loop at a flow rate of 2 l/min toward a UV detector (SpectraFlow 501,
SunChrom) equipped with a nano-flow cell (5 nl) set to record the
absorption at 265 nm. The storage loop and the three pumps were all
connected to a standard 6-port Vici valve (Valco Instruments Co. Inc.)
to control the flow path using a script.
Evaluation of Chromatographic Performance—We loaded 250 ng
of a commercial HeLa digest (Pierce, no. 1862824) spiked in with 100
fmol of PicoSure Test Standard (eight synthetic peptide mix, New
Objective PS-STDN) and loaded the mix on Evotips. For each of the
five gradient methods, four replicates were analyzed using a Thermo
Q Exactive set to acquire full scans (resolution 35k) and targeted MS2
(resolution 17.5k) of the eight synthetic peptides in a scheduled table
(Fig. 6B). Skyline was used to extract between 4 and 6 MS2 ions
(parallel reaction monitoring) for each of the 8 peptides (23). Chro-
matographic profiles were exported from Skyline and peak charac-
teristics for each peak was extracted using a script.
Loading of Evotips—Tips were activated with consecutive 100 l
wash steps of 100% ACN, 50% ACN in 0.5% formic acid in H2O
followed by two times 0.5% formic acid in H2O. BSA or HeLa peptides
were loaded in 0.5% formic acid in H2O. The tip activation protocol
was later optimized to use 1-propanol for wetting the C18 material
prior to equilibration.
High-pressure Liquid Chromatography and Mass Spectrometry—
LC-MS instrumentation consisted of a breadboard Evosep One cou-
pled to an LTQ Orbitrap for the more than 2000 HeLa injection
experiment, and the Evosep One production version coupled to an Q
Exactive HF-X Orbitrap (Thermo Fisher Scientific) for all other exper-
iments. Purified peptides were separated on the HPLC columns with
3 m Reprosil-Pur C18 beads (Dr. Maisch, Ammerbuch, Germany)
and dimensions indicated below in Fig. 6B. On the LTQ Orbitrap MS,
data were acquired with a Top6 data dependent shotgun method and
with a Top12 method for the Q Exactive HF-X instrument. On the Q
Exactive HF-X Orbitrap, the target value for the full scan MS spectra
was 3  106 charges in the 300–1650 m/z range with a maximum
injection time of 50 ms and a resolution of 60,000 at m/z 200. Frag-
mentation of precursor ions was performed by higher-energy C-trap
dissociation (HCD) with a normalized collision energy of 27 eV (24).
MS/MS scans were performed at a resolution of 15,000 at m/z 200
with an ion target value of 5  104 and a maximum injection time of
25 ms. Dynamic exclusion was set to 15 s to avoid repeated sequenc-
ing of identical peptides.
Deep Proteome and DIA Experiments—HeLa cells were harvested
at 80% confluence by washing twice with PBS and subsequently
adding boiling lysis buffer (6 M guanidinium hydrochloride (GndCl), 5
mM tris(2-carboxyethyl)phosphine, 10 mM chloroacetamide, 100 mM
Tris pH 8.5) directly to the plate. The cell lysate was collected by
scraping the plate and boiled for an additional 10 min, followed by
micro tip probe sonication (Vibra-Cell VCX130, Sonics, Newton, CT)
for 2 min with pulses of 1 s on and 1 s off at 80% amplitude. Protein
concentration was estimated by Bradford assay, and the lysate was
digested with LysC (Wako) in an enzyme/protein ratio of 1:100 (w/w)
for 1 h, followed by dilution with 25 mM Tris, pH 8.5, to 2 M GndCl and
further digested overnight with trypsin (1:100 w/w). Protease activity
was quenched by acidification with trifluoroacetic acid (TFA) to a final
concentration of 1%, and the resulting peptide mixture was con-
centrated on Sep-Pak (C18 Classic Cartridge, Waters, Milford, MA).
Elution was done with 2 ml of 40% acetonitrile (ACN), followed by 2
ml of 60% ACN. The eluates were combined and volume reduced by
SpeedVac (Eppendorf, Germany), and the final peptide concentration
was estimated by measuring absorbance at 280 nm on a NanoDrop
spectrophotometer (NanoDrop 2000C, Thermo Fisher Scientific, Ger-
many). For DIA samples, iRT peptides (Biognosys AB, Schlieren,
Switzerland) were added prior to MS analysis according to the man-
ufacturer’s protocol. For samples analyzed on the Evosep One, an
in-house packed 12 cm, 150 m i.d. capillary column with 1.9 m
Reprosil-Pur C18 beads (Dr. Maisch, Ammerbuch, Germany) was
used, while samples analyzed on the Easy-nLC 1200 were separated
in an in-house packed 15 cm, 75 m i.d. capillary column with the
specifications as described above. The column temperature was
maintained at 40 °C using an integrated column oven (PRSO-V1,
Sonation, Biberach, Germany) and interfaced online with the mass
spectrometer.
Data Analysis—MS raw files were analyzed by the MaxQuant soft-
ware (version 1.5.6.8) (3) and fragments lists were searched against
the human Uniprot Reference Proteome without isoforms (April 2017
release with 21,042 protein sequences) by the Andromeda search
engine (25) with cysteine carbamidomethylation as a fixed modifica-
tion and N-terminal acetylation and methionine oxidations as variable
modifications. The experiment for the 200 samples/day method was
analyzed with the UPS1 FASTA file, downloaded from the homepage
of Sigma-Aldrich (April 2018). We set the false discovery rate (FDR) to
0.01 at the peptide and protein levels and specified a minimum length
of 7 amino acids for peptides. Enzyme specificity was set as C-ter-
minal to arginine and lysine as expected using trypsin and LysC as
proteases, and a maximum of two missed cleavages. An initial pre-
cursor mass deviation up to 7 ppm and a fragment mass deviation of
20 ppm were specified.
Data independent analysis (DIA) results were processed with Spec-
tronaut version 11.0.15038.19.19667, using default settings (Biogno-
sys, Zurich, Switzerland). A project specific spectral library was
imported from the separate MaxQuant analysis of the combined
analysis of the 46 pre-fractionated HeLa fractions, and DIA files were
analyzed using default settings. Information about precursors, pep-
tides and proteins identified by the Spectronaut software are available
in Supplemental Table S1 and S2.
All bioinformatics analyses were done with the Perseus software
(26) of the MaxQuant computational platform.
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RESULTS AND DISCUSSION
Principle of Analyte Embedding in Pre-formed Gradients—
Our key idea in making nano-LC as robust as high-flow LC
was to decouple gradient formation from the high resolution,
high-pressure separation on an analytical column. As in es-
tablished peptide purification strategies, the peptides are first
loaded on Evotips (a form of solid phase extraction tips like
StageTips (20)). However, instead of eluting the peptides from
the tips, drying them to remove the organic content and
re-suspending them in injection buffer, we directly elute from
the Evotip into the capillary loop. This is accomplished at
pressures of only a few bar by two syringe pumps A and B at
flow rates of 10 to 20 l/min (Fig. 1). Note that an entire
gradient can be stored in a several meters long fused silica
capillary - already containing the individual peptides at the
organic content where they elute from the C18 material. For
instance, a 4 m long capillary of 100 m inner diameter (i.d.)
has a volume of 31.5 l, enough for a subsequent analytical
column separation of 31.5 min at 1 l/min or 90 min at 350
nl/min.
We first asked if the gradient would be affected over time in
the storage loop due to diffusion (27). Considering the very
high aspect ratio of column length compared with i.d. (40,000
in the example above), this appears to be unlikely. Further, in
a similar capillary storage scheme in the RePlay system we
did not observe such mixing (28). To experimentally investi-
gate this question, we placed defined plugs of ACN/1%
acetone and water in the capillary loop, stored them for 0
or 60 min and monitored them with a UV detector (Fig. 2A,
EXPERIMENTAL PROCEDURES). This did not lead to detect-
able mixing (Fig. 2B), confirming that storage of pre-formed
gradients in a capillary loop is suitable for our purposes.
Having established that an analyte-containing gradient can
be formed easily and stored in a loop, the next challenge was
to obtain high chromatographic resolution with the help of an
analytical column. A common issue in pre-column setups is
peak broadening because peptides eluting from the pre-col-
umn are not sufficiently retained on the analytical column. To
solve this issue, and to take account of the relatively large
elution volume from the Evotip, we designed a gradient offset
strategy. Once the Evotip is sealed in-line with the solvent
system, a gradient from pumps A and B subsequently elutes
the peptides from the tip. Directly after the Evotip, a second-
ary gradient from pumps C and D modifies the composition of
the initial gradient and thus, reduces the effective organic
content (Fig. 3A, 3B). With the offset gradient, peptides eluting
from the loop are shortly retained at the head of the column
and thereby focused (Fig. 3C). After separating on the analyt-
ical column, this results in the highest possible peak capacity.
Note that due to the pre-formed and offset gradient the ana-
lytes are effectively loaded on the column in a sequential
manner. Consequently, only a few percent of total peptide
load is on the column at any given time (for instance, with a
loop of 30 l, a maximum of 3% for a 12 cm, 75 m i.d.
column which has a bed volume of less than one 1 l).
After generation of the gradient, the loop-valve switches the
storage loop in-line with the high-pressure pump and the
analytical column (Fig. 3A). The high-pressure pump then
pushes the pre-formed and offset gradient with embedded,
pre-separated peptides over the analytical column. The fact
that almost all the system’s functionality is contained in the
low-pressure sub-system (Fig. 1), should ensure long life-
time of the mechanical components, and opens for ultra-
precise flow manipulation, at a low risk of critical leaks and
malfunction.
To test the Evosep One separation scheme, we loaded a
BSA digest on an Evotip and eluted it in a 21 min gradient
from an 8 cm analytical column (100 m i.d., 3 m C18
beads). This resulted in low peak widths (4.8 s median FWHM)
and corresponding column capacities. Multiple injections il-
lustrate that the chromatograms are virtually superimposable
(Fig. 3D). An interesting consequence of our design is that it
almost eliminates the loading and washing steps that are
otherwise necessary between injections. Instead, the washing
step is also encoded in the loop composition, and all remain-
ing procedures take less than 3 min. This brings the total
analysis time (injection to injection) very close to actual gra-
dient time (21 min  3 min). (Note that the instrument further-
FIG. 2. UV set up to test gradient storage. A, Flow diagram for testing potential gradient mixing during storage in the capillary loop. B,
Profiles of the acetonitrile and water plugs that were recorded by the UV detector for different storage times. Profiles were almost completely
superimposed, consistent with minimal mixing of the two phases during storage.
Pre-formed Gradient Liquid Chromatography
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more allows a higher flowrate at the beginning of the gradient,
which would further compress the time to appearance of the
first peptides in the gradient.) Compared with conventional
designs, this dramatically increases throughput, especially for
short gradients, while avoiding the complexity and reproduc-
ibility issues of double column designs (29).
Robustness Development and Stress Test—Having estab-
lished the basic principles of operation, we constructed a
breadboard model that incorporates all functional compo-
nents. As far as possible, we chose industry leading standard
components, such as the CTC Analytics auto sampler and Vici
rotary valves, whereas other components were custom de-
signed for our throughput and robustness requirements
(EXPERIMENTAL PROCEDURES). Pump firmware develop-
ment was done in house but for other software development,
we used the Chronos environment, an industry standard and
widely used platform, with a view to integrate our instrument
with the different MS manufacturers.
To fine-tune operation and optimize robustness, we in-
jected 1 g of a tryptic HeLa cell digest over 2000 times in a
consecutive manner. We logged all issues over time and
stopped the test only to optimize hardware or software com-
ponents. In total, 35% of the measurements within the first
250 samples suffered from sample loss due to an imperfect
seal of the autosampler needle and the tip. In a first step, we
optimized the needle, which resulted in an immediate reduc-
tion of errors. After changing the seal between the tip and the
entrance of the flow path as well, these issues were eliminated
(Figs. 3A, 4A). From injection 513 on, all instrument related
issues appeared to be resolved. We then mounted a new
column to test the “partial elution” concept (as described in
EXPERIMENTAL PROCEDURES) in subsequent injections.
Over these 1500 samples the total ion current remained un-
changed until the end of the experiment (Fig. 4B). A few
LC-MS runs were blank, but this turned out to be due to
incorrect manual loading of the corresponding Evotips.
We also recorded the pressure profiles for all runs. Validat-
ing the partial elution concept, there was only a very slight
increase in backpressure, indicating that the column had re-
mained free of deposits and as further evidence of the effect,
FIG. 3. Pre-formed gradient. A, Peptides are eluted from the C18 containing Evotip by pumps A and B. Low pressure pumps C and D form
the final gradient, which is stored in the capillary loop together with the analytes. Subsequently, the valve switches and the high-pressure pump
(H) simply pushes the gradient with its peptides over the analytical column. B, Composition of the gradient resulting from the confluence of the
flows from pumps A, B and pumps C, D (x axis designates the volume entering the storage loop). The proportion of acetonitrile is indicated
on the y axis. C, Analytes embedded in the storage loop are represented in red and as peak intensities. Because of the offset provided by
pumps C and D, peptides are shortly retained at the head of the analytical column and elute with narrow peak widths. D, Comparison of three
base peak chromatograms from a HeLa digest, demonstrating the reproducibility.
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the TICs of runs 1 and 1500 were indeed highly similar and
showing no decay in separation performance of the column.
Pressure profiles of adjacent runs were virtually indistinguish-
able (Fig. 4C).
The Evosep One was intended and constructed for high
throughput applications, with a focus on clinical analysis.
Blood plasma is the most widely analyzed clinical matrix, with
millions of samples drawn daily. Yet it is difficult to analyze
plasma robustly by nano-LC/MS, mainly because of the large
number of non-protein blood components. To demonstrate
clinical applicability of the system, we employed our auto-
mated sample preparation pipeline - termed Plasma Pro-
teome Profiling (Geyer et al. 2016a). Plasma samples were
prepared and loaded on the Evotips in a 96 well format, using
a robotic platform. The total measurement time for the 96
samples on the Evosep One was less than 2 days, corre-
sponding to a throughput of 60 samples per day. Reproduc-
ibility over all 96 independent, parallel sample preparations
and injections of the same original plasma was excellent
(median Pearson correlation coefficient of 0.98) over all runs
(Fig. 5B). For clinical decision making based on the concen-
tration of biomarkers, it is crucial to ensure low carry-over
from one analysis to the next. Therefore, we performed a
cross contamination experiment with six alternating injections
of plasma and blanks (Fig. 5B). The average carry-over was as
low as 0.07% and 80% of this can be traced back to just 20
peptides (Fig. 5C).
Design of Methods for Desired Throughput and Depth—
Based on the principles explained above and the experiences
from the robustness testing on the breadboard model, we
then constructed the production unit. We devised a number of
standard gradients and column combinations tailored to dif-
ferent applications, ranging from high throughput quality con-
trol of low complexity samples, through comprehensive
proteomics using fractionation, to the in depth single run
characterization of complex proteomes. The short gradients
made possible by the Evosep system can be used for low
complex samples and the somewhat longer ones for more
complex samples.
Note that the design choices embodied in the Evosep One
also imply certain limitations, at least in the current version. In
common with previous efforts in “industrialized proteomics”,
we chose to prioritize reliability, robustness and throughput
over certain other parameters. The choice of relatively short
and somewhat larger i.d. columns together with a flowrate of
1 l/min, does not maximize sensitivity (however, this can
easily be adjusted by the user). Likewise, sample introduction
through the Evotip currently results in an elution volume op-
timized for gradients up to 44 min, whereas longer gradients
would lead to broader peaks.
FIG. 4. Robustness evaluation. A, Error frequency during the development phase of the system assessed by consecutive measurements
of HeLa digests. B, The first and last base peak chromatogram of a HeLa digest in a series of 1500 measurements using a 22 min gradient.
C, Pressure profiles over the gradient for the first and last three HeLa digests of the same experiment.
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We characterized the chromatographic performance of
each method using a synthetic peptide mix, spiked into the
complex background of a HeLa digest. Parallel reaction mon-
itoring targeting only the synthetic peptides extracted a de-
tailed elution profile representative of typical proteomic meas-
urements. From this data we calculated peak and retention
time properties for the eluting peptides (Fig. 6A; supplemental
Fig. S10–S14). Fig. 6B shows these data in tabular form for
the optimized gradients and column dimensions for the stand-
ard use cases and sample types.
We first wished to demonstrate the possible throughput on
low complexity samples. We digested the “UPS1 Proteomic
Standard” (EXPERIMENTAL PROCEDURES) and used the 5.6
min gradient with the 2 l/min flow on the 5 cm column (200
samples/day method). In a single day, this resulted in 200
data sets with very consistent protein coverage (Fig. 6C). The
UPS1 should contain 48 different proteins but curiously four
of them were never identified. As this standard is equimolar
this is not an issue of dynamic range. Furthermore, the re-
maining 44 proteins were quantified essentially completely in
all runs (average of 43.5  1) (Fig. 6C). We conclude that the
remaining proteins were likely missing from the kit. The high
throughput for low complexity samples would be very inter-
esting for single protein identification experiments in gel
bands, for instance, or for contaminant analysis in recombi-
nant protein expression in biotechnology. In many cases, it
could also be enough for somewhat more complex mixtures
such as those resulting from pull-down experiments.
Rapid Generation of In-depth Mammalian Cell Line Pro-
teomes—Having shown the applicability of the system for low
complexity samples in high throughput, we next investigated
the rapid characterization of fractionated, high complexity
proteomics samples. A fractionation step is very common in
the analysis of cell line or tissue proteomes, but usually comes
with the caveat of a drastic increase in measuring time as the
number of factions increases.
We built on a recently described strategy that combined
extensive high pH reversed-phase peptide pre-separation in a
first HPLC dimension without “concatenation” of the resulting
fractions and relatively short gradients (4). Up to 70 such
fractions were analyzed in gradients of 30 min, allowing for
overall high peptide loading and high combined peak capacity
and making optimal use of the high acquisition speed of
state-of-the-art mass spectrometers (30). This resulted in a
very deep coverage of cell line and tissue proteomes, on par
with RNA-seq results (4). A bottleneck of the workflow was the
low utilization of the mass spectrometer, due to the washing,
equilibration and loading times of the HPLC, which are mini-
mized with the Evosep system.
To characterize the efficiency for fractionated proteomes
and to compare this to the Easy-nLC 1200 used as a standard
in our laboratories as well as in the study described above, we
performed an analysis of 46 HeLa fractions on both systems.
Each of the fractions was divided and separately measured
on the Easy-nLC and the Evosep One on the same MS
instrument, recording total instrument time, the time utilized
for gradients and the numbers of peptides and proteins
identified. The Easy-nLC 1200 was run with our previously
optimized 15 min gradients, whereas we used the 21 min
gradient of the 60 proteomes/day method for the Evosep
One.
As expected because of the short overhead time between
runs, the Evosep One was significantly more efficient in terms
of utilization of the mass spectrometer. A full 88% of the total
analysis time of 18.4 h was spent on data acquisition (Fig. 7A).
In contrast, the Easy-nLC 1200 occupied the mass spectrom-
eter for 28.3 h, but only 14.6 h (52%) were productively used.
This difference did not come at the expense of the numbers of
identified peptides and proteins, which was very comparable
with 132,850 peptides (9918 proteins) and 130,450 peptides
(9603 proteins) for the Evosep One and the Easy-nLC 1200,
respectively. A detailed view of peptides identified in each
FIG. 5. Clinical applicability to the plasma proteome. A, Retention time stability of selected peptides spanning a range of elution times over
96 plasma proteome runs. B, Pearson correlation matrix comparing all 96 plasma runs to each other. A single correlation graph with the median
Pearson value is shown in the inset. C, Summed total peptide intensities in alternating plasma and blank runs.
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fraction separately or cumulatively, showed that they are very
similar (Fig. 7B, 7C). This confirms our conclusion that the
design principle of the Evosep One resulted in saving sub-
stantial measurement time (35% in this case), at undiminished
performance. For longer gradients, the proportional time sav-
ings would be lower, however, given the high price of modern
mass spectrometers, they would still be economically attrac-
tive. The above experiments show that the Evosep is well
suited for the in-depth characterization of proteomes via the
rapid analysis of the high pH or other fractions that are com-
monly used in proteomics. While we employed label-free
quantitation here, the results should equally apply to isobaric
labeling strategies. We also note that an average of 2700
proteins were identified in these fractions. There are several
proteomics strategies that produce many fractions, such as
thermal shift assays (31) or organellar proteomics (32), and
our approach opens up for strategies to rapidly and robustly
measure these.
Single Shot, High Throughput HeLa Proteomes Using DIA—
The experiments described so far used data dependent ac-
FIG. 6. Evosep One methods and chromatographic performance. A, Extracted peaks of synthetic peptides (colored) in a HeLa
background (gray). The inset illustrates the extracted peak properties. B, For ease of use, five optimized methods have been pre-set to provide
the best performance to time compromise. They are defined by the total number of samples that can be run per day rather than referring to
the length of the gradient. The peak width and peak capacity values are averages on a HeLa digest with spiked in synthetic peptides (for details
see supplemental Fig. S10–S14). C, Technical replicates of a digest of the UPS1 Proteomic Standard were injected 200 times with the 200
samples/day method. The number of identified proteins for each sample is shown as a bar graph in chronological order.
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quisition (DDA). However, data independent acquisition
(DIA) is becoming increasingly popular and competitive (7). In
our hands, we have found DIA to perform particularly well with
relatively short gradients on fast and high resolution Orbitrap
analyzers (5). The Evosep One with its fast turn-around be-
tween runs appeared to be a good addition to this strategy
and we were curious to see how deep the proteome could be
covered with such a combination. For this purpose, we made
use of the very extensive peptide library generated in our
previous experiments of the 46 fractions of HeLa digests
using the Spectronaut software with one percent FDR at both
precursor and protein levels.
Especially in short gradients, there is a trade-off between
the number of peptide identifications and the quantification
accuracy because of the finite time for a DIA cycle. To inves-
tigate this, we designed a faster (2 s cycle time, 15k MS/MS
resolution) and a slower scanning method (4 s cycle time, 30k
MS/MS resolution) as visualized in Fig. 8A. Given the short 21
min gradients (60 samples per day) the proteome coverage
was very high for both methods with more than 5000 quanti-
fied proteins from more than 40,000 matched peptides. This
equates to 250 unique proteins per gradient minute through-
out the gradient. As expected, the slower method was some-
what superior in terms of identifications with a higher number
of precursors (88,133 versus 81,007), peptide identifications
(46,570 versus 40,642) and protein groups (5446 versus 5055)
(Fig. 8B). For the fast and the slow method, the overlap of
proteins between replicates was 81% and 85%with 4491 and
4904 proteins found in all five measurements, respectively
(supplemental Fig. S15A). The faster method performed better
with regard to protein quantification with 3286 proteins with a
CV less than 20% in the slower versus 2724 in the faster
method, respectively (Fig. 8C, supplemental Fig. S15B).
For the top 70% of the proteome by abundance, data com-
pleteness was close to 100% (supplemental Fig. S15C).
These results indicate that the short gradients enabled by
FIG. 7. Rapid generation of mammalian cell line proteomes. A,
Table for the comparison of the Evosep One with the Easy-nLC 1200,
including total measurement time, gradient time and the numbers for
identified proteins and peptides. B, Numbers of identified peptides
per fraction over the 46 high pH reversed-phase fractions for both LC
systems. C, Cumulative numbers of unique peptides across the
fractions.
FIG. 8. Rapid generation of mammalian cell line proteomes. A,
Two scan modes for the acquisition of DIA data were devised and
tested. B, Average number of precursors, identified peptides and
protein groups for five HeLa measurements with 21 min gradients on
the Evosep One. C, Number of proteins quantified with a coefficient of
variation (CV) below 20 and 10%.
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the Evosep One can very efficiently be combined with DIA
for high-throughput and in-depth acquisition of proteomic
data.
CONCLUSION
Despite the great technological advances in high sensiti-
vity nano-flow MS-based proteomics, the robustness and
throughput have been weak links even in state of the art
MS-based proteomic workflows. This has led to a move to-
ward microflow systems—especially with a view toward clin-
ical applications—however, at the cost of sensitivity (33).
Here, we have introduced an entirely novel concept based on
the pre-formation of gradients at relatively high-flow and low-
pressure. This pre-stored gradient already has the analytes
embedded and is moved across a high-resolution column by
a single, high-pressure pump. Based on these principles, we
first designed a breadboard system that was progressively
developed into a commercial HPLC system - the Evosep One.
We established that pre-storing of the gradient, followed by
“re-focusing” of the peaks at the head of the analytical col-
umn, assures full chromatographic peak capacity of the over-
all system. Together with the Evotip as a disposable sample
clean up cartridge, the system is designed for sensitivity,
throughput, and robustness - tailor made for large clinical
studies. To test this, we performed thousands of runs with cell
lysates as well as complex clinical samples such as blood
plasma. We found that the decoupling of gradient formation
with a low-pressure system and the high-pressure peptide
separation ensured stable and uninterrupted operation with-
out instrument related issues or deterioration in chromato-
graphic performance. As expected from its design, the
Evosep One proved to have minimal or absent cross contam-
ination and very high consistency of label-free quantitation
results across injections.
The time required for the formation of the pre-stored gra-
dient, including the washing step, happens within 2–3 min,
reducing the idle time of the mass spectrometer between
injections. This opens up for the rapid analysis of samples of
medium complexity, as we demonstrated with the measure-
ment of 200 standard mixtures (UPS1) in a single day. The
short gradients on the Evosep One are especially attractive in
combination with time-of-flight (TOF) instruments because of
their very high scanning speed. This was recently demon-
strated by the identification of more than 1000 HeLa proteins
in only 5.6 min (200 samples/day method) (34). Deep pro-
teomes are typically achieved after extensive fractionation. In
this context, the fast turn-around of the Evosep One ensures
very high utilization of the MS instrumentation as we show by
the analysis of 46 HeLa fractions in 18 h. Finally, we used a
state-of-the-art data independent workflow that enabled a
remarkable proteome depth of 5200 proteins in only 21 min
(60 samples/day method). With ongoing developments on the
mass spectrometric side, the proteome coverage is likely to
improve further.
The minimal run-to-run times make even very short gradi-
ents efficient and attractive, opening up for high-throughput
proteomics in areas like screening of host-cell proteins in
pharma research, protein interaction studies and in particular
clinical proteomics. We further imagine applications in top-
down proteomics and in small molecule analysis, in particular
metabolomes.
Acknowledgments—We thank all members of the department of
Proteomics and Signal Transduction at the Max Planck Institute of
Biochemistry in Martinsried for help and discussions, and Gaby Sowa
for technical assistance.
DATA AND MATERIAL AVAILABILITY
The MS-based proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner reposi-
tory and are available via ProteomeXchange with the identifier
PXD010393. Tables containing all identified proteins are avail-
able with accession number, sequence coverage, number of
identified peptides and quantitative values (Supplemental Ta-
bles S1–6).
* This work was partially supported by the Max Planck Society for
the Advancement of Science, the European Unions Horizon 2020
research and innovation program (grant agreement no. 686547;
MSmed project) and by the Novo Nordisk Foundation (grant
NNF14CC0001).
□S This article contains supplemental Figures and Tables. The au-
thors state that they have potential conflicts of interest regarding this
work: NB, OH, LF, OV, are employees of Evosep and MM is an
indirect investor in Evosep.
** To whom correspondence should be addressed: Department of
Proteomics and Signal Transduction, Max Planck Institute of Bio-
chemistry Martinsried, Germany. E-mail: mmann@biochem.mpg.de.
 These authors contributed equally.
Author contributions: N.B., P.E.G., O.H., L.F., J.V.O., O.V., and
M.M. designed research; N.B., P.E.G., D.B.B.-J., O.H., L.F., P.V.T.,
S.D., I.P., J.B.M., F.M., and O.V. performed research; N.B., P.E.G.,
D.B.B.-J., O.H., L.F., P.V.T., S.D., J.V.O., and M.M. analyzed data;
N.B., P.E.G., and M.M. wrote the paper; O.H., L.F., I.P., and O.V.
contributed new reagents/analytic tools.
REFERENCES
1. Aebersold, R., and Mann, M. (2016) Mass-spectrometric exploration of
proteome structure and function. Nature 537, 347–355
2. Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., and Mann, M. (2014)
Minimal, encapsulated proteomic-sample processing applied to
copy-number estimation in eukaryotic cells. Nat. Methods 11,
319–324
3. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-wide
protein quantification. Nat. Biotechnol. 26, 1367–1372
4. Bekker-Jensen, D.B., Kelstrup, C. D., Batth, T. S., Larsen, S. C., Haldrup,
C., Bramsen, J. B., Sørensen, K. D., Høyer, S., Ørntoft, T. F., Andersen,
C. L., Nielsen, M. L., and Olsen, J. V. (2017) An optimized shotgun
strategy for the rapid generation of comprehensive human proteomes.
Cell Systems 4, 587–599
5. Kelstrup, C. D., Bekker-Jensen, D. B., Arrey, T. N., Hogrebe, A., Harder, A.,
and Olsen, J. V. (2018) Performance evaluation of the Q Exactive HF-X
for shotgun proteomics. J Proteome Res, 17, 727–738
6. Kulak, N.A., P.E. Geyer, and Mann, M. (2017) Loss-less nano-fractionator
for high sensitivity, high coverage proteomics. Mol. Cell. Proteomics
Manuscript in Press, 2017
Pre-formed Gradient Liquid Chromatography
Molecular & Cellular Proteomics 17.11 2295
 by guest on D
ecem
ber 17, 2018
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
7. Bruderer, R., Bernhardt OM, Gandhi T, Xuan Y, Sondermann J, Schmidt M,
Gomez-Varela D, Reiter L. (2017) Optimization of experimental param-
eters in data-independent mass spectrometry significantly increases
depth and reproducibility of results. Mol. Cell. Proteomics 16,
2296–2309,
8. Meier, F., Geyer, P. E., Virreira, Winter, S., Cox, J., and Mann, M. (2018)
BoxCar acquisition method enables single-shot proteomics at a depth of
10,000 proteins in 100 minutes. Nat. Methods doi:10.1038/
s41592-018-0003-5
9. Riley, N. M., Hebert, A. S., and Coon, J. J. (2016) Proteomics Moves into
the Fast Lane. Cell Syst, 2, 142–143
10. Picotti, P., and Aebersold, R. (2012) Selected reaction monitoring-based
proteomics: workflows, potential, pitfalls and future directions. Nat.
Methods 9, 555–566
11. Gillet, L. C., Leitner, A., and Aebersold, R. (2016) Mass spectrometry
applied to bottom-up proteomics: entering the high-throughput era for
hypothesis testing. Annu. Rev. Anal. Chem. 9, 449–472
12. Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., and Mann, M.
(2014) Accurate proteome-wide label-free quantification by delayed nor-
malization and maximal peptide ratio extraction, termed MaxLFQ. Mol.
Cell. Proteomics 13, 2513–2526
13. Geiger, T., Wehner, A, Schaab, C, Cox, J, Mann, M. (2012) Comparative
proteomic analysis of eleven common cell lines reveals ubiquitous but
varying expression of most proteins. Mol. Cell. Proteomics 11,
M111.014050
14. Geyer, P. E., Holdt, L.M., Teupser, D., and Mann, M. (2017) Revisiting
biomarker discovery by plasma proteomics. Mol Syst Biol, 13, 942
15. Liu, Y., Hu¨ttenhain, R., Collins, B., and Aebersold, R. (2013) Mass spectro-
metric protein maps for biomarker discovery and clinical research. Expert
Rev. Mol. Diagn. 13, 811–825
16. Geyer, P. E., Kulak, N. A., Pichler, G., Holdt, L. M., Teupser, D., and Mann,
M. (2016) Plasma proteome profiling to assess human health and dis-
ease. Cell Syst. 2, 185–195
17. Geyer, P. E., Wewer Albrechtsen, N. J., Tyanova, S., Grassl, N., Iepsen,
E. W., Lundgren, J., Madsbad, S., Holst, J. J., Torekov, S. S., and Mann,
M. (2016) Proteomics reveals the effects of sustained weight loss on the
human plasma proteome. Mol. Syst. Biol. 12, 901
18. Falkenby, L. G., Such-Sanmartín, G., Larsen, M. R., Vorm, O., Bache, N.,
and Jensen, O. N. (2014) Integrated solid-phase extraction-capillary
liquid chromatography (speLC) interfaced to ESI-MS/MS for fast char-
acterization and quantification of protein and proteomes. J. Proteome
Res. 13, 6169–6175
19. Ishihama, Y., Rappsilber, J., and Mann, M. (2006) Modular stop and go
extraction tips with stacked disks for parallel and multidimensional Pep-
tide fractionation in proteomics. J. Proteome Res. 5, 988–994
20. Rappsilber, J., Ishihama, Y., and Mann, M. (2003) Stop and go extraction tips
for matrix-assisted laser desorption/ionization, nanoelectrospray, and
LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663–670
21. Wisniewski, J. R., Dus, K., and Mann, M. (2013) Proteomic workflow for
analysis of archival formalin-fixed and paraffin-embedded clinical
samples to a depth of 10 000 proteins. Proteomics Clin. Appl. 7,
225–233
22. Binai, N. A., Marino, F., Soendergaard, P., Bache, N., Mohammed, S., and
Heck, A. J. (2015) Rapid analyses of proteomes and interactomes using
an integrated solid-phase extraction-liquid chromatography-MS/MS
system. J. Proteome Res. 14, 977–985
23. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L.,
Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J.
(2010) Skyline: an open source document editor for creating and
analyzing targeted proteomics experiments. Bioinformatics, 26,
966–968
24. Olsen, J. V., et al. (2007) Higher-energy C-trap dissociation for peptide
modification analysis. Nat. Methods 4, 709–712
25. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and
Mann, M. (2011) Andromeda: a peptide search engine integrated into the
MaxQuant environment. J Proteome Res, 10, 1794–1805
26. Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M., Geiger, T., Mann,
M., and Cox, J., (2016) The Perseus computational platform for compre-
hensive analysis of (prote)omics data. Nat. Method 13, 731–740
27. Davis, M. T., Stahl, D. C., and Lee, T. D. (1995) Low flow high-performance
liquid chromatography solvent delivery system designed for tandem
capillary liquid chromatography-mass spectrometry. J. Am. Soc. Mass
Spectrom. 6, 571–577
28. Waanders, L. F., Almeida, R., Prosser, S., Cox, J., Eikel, D., Allen, M. H.,
Schultz, G. A., Mann, M. (2008) A novel chromatographic method
allows on-line reanalysis of the proteome. Mol. Cell. Proteomics 7,
1452–1459
29. Hosp, F., Scheltema, R. A., Eberl, H. C., Kulak, N. A., Keilhauer, E. C., Mayr,
K., and Mann, M. (2015) A double-barrel liquid chromatography-tandem
mass spectrometry (LC-MS/MS) system to quantify 96 interactomes per
day. Mol. Cell. Proteomics 14, 2030–2041
30. Kelstrup, C. D., Jersie-Christensen, R. R., Batth, T. S., Arrey, T. N., Kuehn,
A., Kellmann, M., and Olsen, J. V. (2014) Rapid and deep proteomes by
faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap
mass spectrometer. J. Proteome Res. 13, 6187–6195
31. Savitski, M. M., Reinhard, F.B., Franken, H., Werner, T., Savitski, M.F.,
Eberhard, D., Martinez Molina, D., Jafari, R., Dovega, R.B., Klaeger, S.,
Kuster, B., Nordlund, P., Bantscheff, M., and Drewes, G. (2014) Tracking
cancer drugs in living cells by thermal profiling of the proteome. Science
346, 1255784
32. Itzhak, D.N., Tyanova, S., Cox, J., and Borner, G.H. (2016) Global, quanti-
tative and dynamic mapping of protein subcellular localization. Elife, 5
33. Fu, Q., Kowalski, M. P., Mastali, M., Parker, S. J., Sobhani, K., van den
Broek, I., Hunter, C. L., and Van Eyk, J. E. (2018) Highly reproducible
automated proteomics sample preparation workflow for quantitative
mass spectrometry. J. Proteome Res. 17, 420–428
34. Meier, F., et al. (2018) Online parallel accumulation – serial fragmentation
(PASEF) with a novel trapped ion mobility mass spectrometer bioRxiv
doi: https://doi.org/10.1101/336743
Pre-formed Gradient Liquid Chromatography
2296 Molecular & Cellular Proteomics 17.11
 by guest on D
ecem
ber 17, 2018
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
